9999999997-12-000964.txt : 20120217 9999999997-12-000964.hdr.sgml : 20120217 20120217102837 ACCESSION NUMBER: 9999999997-12-000964 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120217 DATE AS OF CHANGE: 20120217 20120217 20120217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 12621299 BUSINESS ADDRESS: STREET 1: 3930 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-332-7800 MAIL ADDRESS: STREET 1: 3930 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19940606 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(.)-C5@,0G0P8F1H:=(%D&1G3B/^.L/P`!!@"SE@;D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU-"`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*><@94P,@` MDN5H0!9C@6(&AAL,W`R<_]59%D"5RG%#:*849,6&YR&BC.8``08`#I,%_@T* M96YD7!E+U!A9V4^/@UE;F1O8FH--#4@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I=D2SH2AT^SQ8UZL-RTQ1M+W>6>ZD,S2V39; M-T0J.JO*=C*I?MU?:)V@C0C&&"9X0.LLVQ7;YS>+8IL=Q!:T_G3CQ;H+.JG''D%F?O3W$.*(RLB&IO@%H3Q41@N&J8=5]DA/$[A4W?.(:HG",3`0_6=%","'D#6<[!.(Z2WV6$/BX,]E:)=^J9: MUP0U3$RWW\5;/4!'AS1&.$$JO8()V@)F#CR>@:&W6VW(:Y=#D\8&Y3]_N/[U-\!_R=0`[]G0);$MTO M[P>Q*+>` MYP3N(#^HMN!W6FVA>A1;SE^(K5>#%V*;)F=H;<3`&BC=A#'P>Z>T5FFYK[7\ MI=:JZ(C&@$+]GS>&+];C6#RVWQS/[R7OD)P"X-M_++7'X*7V.)S4_A9@`-BN M>=L-"F5N9'-TQ`$4"2[=5NK@?-V.&!7UX/'@,V>88,]S[97UT41,,F*CU=2 MP1ZL%'$SA!5[]'S)BSXL MBYM'[\_B%W`*E`1X/A5YAJMS<<36-IE4=$XOP+:,1)K4C8.EA-]X?LP'[Q_N M/#_D!;[0BK9)@/5'0T:O?W@RX(.?/3_B_=%/GCG+!K_CSKWG9_!0^CB=I`>] MDL2H$ MTK/'5"`5+5?\>5=$<#H\ MXO7(!D-FB3.:+=](.DVX-MGZ`Q)GA``"P*3G*Y[C(\1'U(XKEEUQ2==V_#`0 M*KZ462D[&"JE2&0=B#[Z-$=R+DIT>>MXRMX!>Y<-VFX@(GB5$9\MB-)[[`8K MA&2F]]>X?D8,>J3E#I>D=29.(L+\8N"N]_F)B*/C0I3DI4+W M%%]XX,<(J%8*[0X/`O*"ZB\6@6UB/KX'(@S-NU1Q%E7^ZM_#2IYV"79I89<8 MY)@//#_GMS\TDU]Q6NFJ3]*@`P_7N_U`I6C][DN]75%]_>U)Q-H/-$G[P>-HBZVLDI)F&"PV)+^R!MAJS_#L%ZIO5(U^68OX?S,= M8]`7$F@EI8$1IDN"Z`9B^4)I7JZ\C$^K%%'BM&A)Z6&W&":JT5K("C(RJ^KR MQ!P(1&9Q_U7CWG#LN$?,&>295)]HI6.X,*`_2+K/^%ALD"=3XN*"N-P.7E%X MLJ>IH)L(C'G9:Q>(M3(AMK,):5]LT=*6$MI329FGASP#>U%R45&"`-!V& MMNMM!BZ.R7?J,Q+G6+O'4(MI=)AVQ=9;S7[I*5UD2V^BN=EQ4 MC;SZ*A%)5F\$GPX(6=6@'',=N,SE`AH"(N5$*OBV%>9.G9:FFMI8A9@_W&Y( MEKKSH3:G?$L-](0P0@L_HV!5M9TMM=87R`86O"$0U@$RS'20\J-KP<#+,5S5 M9$@C03O680_I-+.;/?@Z>0\;XA&3+&!@@QK!XEA]X*!A^L&#)RTC6O9:+@X] MH_KSRC4M:TH[.^3^S*2QU59(C56,6S(%(S$$G]&GM^]_X M2;;651J+,+7E057=8ZCMBPN2[!SFQG/,+\GV]9EB\)4W1J9F`S([LM9VUV`;<;-R7]*1+-HGO MS&3'\^L5#M3C@4RMA"3WJXT[L=#W@]:$MX0-_3)VY&V:9E M2U+J.I3H;ZT.J7.8RQMHI(1/ZBU27_`/FA7DFJUW:GT&C1>6XKS5?'IE+E)Y M5WFHZLLS%7EZ,:U1*ZTMD?B_%]"EER[J#`&7B?D(H#:Q9O>>=&RBYO+Q]=Z^BJMU@W MPDM$E-:M*1&'G>%6MVEUF0+MJS2)W!17_PHP`)AA^;L-"F5N9'-TY!@9$1FEP'Z> M@8V!F0$,$I.+"QP#`GQ`[+S\O%0&#/#M&@,CB+ZL"S(+4QXO8$TN*"H!T@>` MV"@EM3@92'\!XLSRD@*@.&,"D"V2E`UF@]2)9(<$.0/9'4`V7TEJ!4B,P3F_ MH+(H,SVC1,'0TM)2P3$E/RE5(;BRN"0UMUC!,R\YOZ@@ORBQ)#4%J!9J!PCP MNQ`P8A0[CQ!#@.32HC(HDY')F($! M(,``2<8X+PT*96YDW)+!;MLP#(9?A6\@BY1L&2@"=-T*#,6R(,E.10]> M*J3&6MMP':!]^_TVLVX[C+WODA\2F4_T)Y544$5)*)$4B6H2KL@7%%G(>ZKF M%5,5$4)50@1*'A$I!41)J4)45!<(``114UU6Q`75-<*#!PPS,B::P46JB0,. M0`]'9/3$)3(Q+2?B,$[($(AK9!4Q'D8H2A+P!*<(>%)B;/"DQN#@!30)>*'T M)."%FFD>:/X:`2_&0`)>3)$N+MP-/KV@K=LT8^ZF_9@S-/R]L^V M_6/^T@Q0-'?L7X?L=M-X.BQMV[Z?5JL9>0MK:)BM+2$:02-JE!J51M)8P+.U M)93"2F&EL%)8*:P45@HKA94B2A&EB%)$*:(448HH190B2I&%>N'IIQ4]/@?SV1^Y/TWEY M^OY\&-OA;3GD\<^-/2[R0__B+C':M^X^CV^DU>I_NK/E61>XN?/3/E((YSO< MZ`O%6[:J;%;%K`:S&LUJ:58KLYK,:FW;>$>6;FMC.60B/SX*/'@Z>&UP;65T82!X;6QN M#IX;7!T:STB061O8F4@6$U0($-O&UP M.DUE=&%D871A1&%T93XR,#$R+3`R+3$W5#$P.C(W.C4T+3`U.C`P/"]X;7`Z M365T861A=&%$871E/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%C&UP34TZ26YS M=&%N8V5)1#YU=6ED.CDU,3(R.#!E+60Q-C`M-&)C,BUA83@S+3&UP34TZ26YS=&%N8V5)1#X*("`@("`@("`@/'AM<$U-.G-U8FIE M8W0^"B`@("`@("`@("`@(#QR9&8Z4V5Q/@H@("`@("`@("`@("`@("`\7=O#I3;W5R8V5-;V1I9FEE9#X*("`@("`@("`@/'!D9G@Z0V]M M<&%N>3Y396-U&AA;F=E($-O;6UI3X*("`@("`@("`@/'!D9G@Z0V]M;65N=',^5F5R'L/WOLI-R2=B M55)5;^ERP9B3>D).@2*8N?Z^OKLXJ@,.A4,.F,!%#[>?)Q=?$*922!,N**/+ MDCJ7475+JXW5UK1&V[:YOM+-3.O9#R63FX&I=QGVW=W.G9'A9F[@2`S/Q+ZJ M[W'\D)!45>_(_Z=<_"KW3+X,*$Y//4Y&>`@].QY%*C\0WY#5:W77P(,`(>B6%`-"F5N9'-T